Previous Close | 6.10 |
Open | 6.10 |
Bid | 3.00 |
Ask | 7.90 |
Strike | 200.00 |
Expire Date | 2024-08-16 |
Day's Range | 6.10 - 6.10 |
Contract Range | N/A |
Volume | |
Open Interest | 7 |
BeiGene Canada, the country affiliate of global oncology company BeiGene, specializing in the discovery and development of novel, affordable, and accessible oncology medications, has opened its first office in Canada. Situated in downtown Toronto, the new office space will be the Canadian headquarters where the company will work to extend the boundaries of 'the possible,' fulfilling BeiGene's promise of delivering best-in-class, innovative treatments to the Canadian cancer community.
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass., April 26, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, released its 2023 Responsible Business & Sustainability Report highlighting the Company’s strategy, the progress it has made towards existing goals, and how it intends to achieve its bold new targets.
In this article, we will be taking a look at the 20 countries with the highest rates of stomach cancer in the world. If you do not want to learn about the global cancer trends, head straight to the 5 Countries with the Highest Rates of Stomach Cancer in the World. Overview of the Global […]